Comparisons Tirzepatide vs Retatrutide

Tirzepatide vs Retatrutide

Side-by-side comparison of weight loss results, pricing, side effects, and clinical data.

Tirzepatide

~22%

Retatrutide

~24%

Head-to-Head Comparison

Metric
TirzepatideMounjaro / Zepbound
RetatrutideNot yet approved
Drug Class
GLP-1/GIP dual agonist
GLP-1/GIP/Glucagon triple agonist
Administration
Weekly injection
Weekly injection
Dosing
Once weekly
Once weekly
Avg. Weight Loss
~22%
~24%
Half-Life
~5 days
~6 days
Compounded Cost
$150-450/mo (compounded)
Not yet available
Brand Cost
$1,000-1,200/mo
Not yet available
FDA Approved
2022
Key Trial
SURMOUNT-1 (22.5% weight loss)
Phase 2 (up to 24.2% weight loss at 48 weeks)

Side Effects Comparison

Tirzepatide

  • Nausea
  • Diarrhea
  • Decreased appetite

Retatrutide

  • Nausea
  • Diarrhea
  • Vomiting

Pros & Cons

Tirzepatide

Pros

  • +FDA-approved and available now
  • +Strong clinical evidence
  • +Dual mechanism proven effective

Cons

  • -Dual vs triple receptor
  • -May be surpassed by next-gen drugs

Retatrutide

Pros

  • +Triple receptor targeting
  • +Potentially more weight loss
  • +May boost energy expenditure via glucagon

Cons

  • -Not yet available
  • -Only Phase 2 data
  • -Unknown pricing and insurance landscape

The Verdict

Both are Eli Lilly products. Tirzepatide is available now and highly effective (~22% weight loss). Retatrutide adds a third receptor (glucagon) and early data suggests slightly more weight loss (~24%), but it needs Phase 3 confirmation. Tirzepatide is the best available option today; retatrutide could be the future.

No head-to-head trials. Both from Eli Lilly; retatrutide is in Phase 3 while tirzepatide is commercially available.

Which Is Right for You?

Choose Tirzepatide if...

Patients who need the most effective available medication right now

Choose Retatrutide if...

Future option — currently in clinical trials, not commercially available

Frequently Asked Questions

Will retatrutide replace tirzepatide?

It is unlikely to fully replace tirzepatide. They may serve different patient populations. Eli Lilly will likely market both, as they do with Mounjaro and Zepbound today.

How much better is retatrutide than tirzepatide?

Phase 2 data shows retatrutide achieving ~24% weight loss at 48 weeks vs tirzepatide's ~22% at 72 weeks. The additional glucagon component may also improve liver fat and metabolic health.

Should I wait for retatrutide instead of starting tirzepatide?

No. Retatrutide is likely 1-2+ years from approval. If you need treatment now, tirzepatide is an excellent and proven option. You could always switch later if retatrutide proves superior.

Find a provider prescribing Tirzepatide or Retatrutide

Compare pricing, reviews, and availability across 18,000+ GLP-1 providers nationwide.

Search Providers →

View all GLP-1 comparisons

Compare every major GLP-1 medication side by side. Weight loss data, cost analysis, and clinical trial results.

All Comparisons →